D.C. Mun. Regs. tit. 17, r. 17-10000

Current through Register Vol. 71, No. 50, December 13, 2024

Rule 17-10000 - GENERAL PROVISIONS

10000.1

Participation in a collaborative practice agreement shall be voluntary, and no licensed physician, pharmacist or institution shall be required to participate.

10000.2

Neither a pharmacist nor physician shall provide economic incentives to the other for the purpose of entering into a collaborative practice agreement.

10000.3

A physician shall not be employed by any pharmacist or pharmacy for the sole purpose of collaborative practice.

10000.4

Patient entry into a collaborative practice arrangement shall be initiated by an authorizing protocol that includes coverage of the patient(s), or a written referral from the licensed physician to the pharmacist for a specific patient.

10000.5

When patient entry is initiated by the pharmacist, the pharmacist shall:

(a) Instruct the patient to follow up with the authorizing physician within the time period established in the collaborative practice agreement;

(b) Notify the authorizing physician of the encounter in writing within twenty-four (24) hours or one (1) business day; and

(c) Obtain a referral from the authorizing physician before providing further collaborative practice services to the patient.

10000.6

A pharmacist who is a party to a collaborative practice agreement shall utilize an area for in person, telephonic or other approved ele ctronic consultations relating to the management of drug therapy that ensures the confidentiality of the patient information being discussed.

10000.7

Nothing in these regulations shall be construed or interpreted to allow a pharmacist to accept delegation of a physician's authority outside of or beyond the scope of the pharmacist's practice.

D.C. Mun. Regs. tit. 17, r. 17-10000

Final Rulemaking published at 65 DCR 8528 (8/17/2018)